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Abstract
A novel membrane proteinase of the nosocomial important bacteria species Bacillus cereus (synonyms: camelysin, CCMP)
was purified up to homogeneity as was shown by mass spectrometry in its amphiphilic form. Camelysin is a neutral
metalloprotease with a molecular mass of 19 kDa. Its unique N-terminus Phe-Phe-Ser-Asp-Lys-Glu-Val-Ser-Asn-Asn-Thr-
Phe-Ala-Ala-Gly-Thr-Leu-Asp-Leu-Thr-Leu-Asn-Pro-Lys-Thr-Leu-Val-Asp-(Ile-Lys-Asp)- was not detected in the protein
data bases during BLAST searches, but in the partially sequenced genome of Bacillus anthracis, coding for an unknown
protein. Cleavage sites of the membrane proteinase for the insulin A- and B-chains were determined by mass spectrometry
and N-terminal sequencing. Camelysin prefers cleavage sites in front of aliphatic and hydrophilic amino acid residues (^OH,
^SO3H, amido group), avoiding bulky aromatic residues. The internally quenched fluorogenic substrates of the matrix
metalloproteases 2 and 7 were cleaved with the highest efficiency at the Leu-s-Gly or Leu-s-Ala bond with the smaller
residue in the P1P position. The protein specificity is broad ^ all various kinds of casein were cleaved as well as acid-soluble
collagen, globin and ovalbumin; intact insulin was destroyed only to a low extent. Actin, collagen type I, fibrinogen, fibrin,
K2-antiplasmin and K1-antitrypsin were cleaved. The protease formed SDS-stable complexes with Glu-plasminogen and
antithrombin III, visible after SDS electrophoresis by gold staining and Western blot. The CCMP^plasminogen complex
caused a partial activation of plasminogen to plasmin. Camelysin interacts with proteins of the blood coagulation cascade
and could facilitate the penetration of fibrin clots and of the extracellular matrix during bacterial invasion. ß 2001 Elsevier
Science B.V. All rights reserved.
0925-4439 / 01 / $ ^ see front matter ß 2001 Elsevier Science B.V. All rights reserved.
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Abbreviations: ACE, angiotensin-converting enzyme; AMC, aminomethylcoumarylamide; BCA, bicinchoninic acid; Boc, t-butyloxy-
carbonyl; Bz, benzyl; CCMP, casein-cleaving membrane protease; CK, chloromethylketone; CMC, critical micelle concentration;
DEPC, diethylpyrocarbonate; DL-thiorphan, DL-3-mercapto-2-benzyl-propanoyl glycine; Dpa, N-3-(2,4-dinitrophenyl)-L-2,3-diaminopro-
pionyl ; DTT, dithiothreitol ; FAGLA, furylacroleyl-Gly-Leu-NH2 ; FALGPA, furylacroleyl-Leu-Gly-Pro-Ala-NH2 ; Glp, pyroglutamyl;
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1. Introduction
Bacillus cereus is an aerobic, endospore-forming,
mobile Gram-positive rod, but grows well anaerobi-
cally. The genus also includes Bacillus thuringiensis
and Bacillus anthracis. Whereas the latter is well
known to be the causative agent of anthrax for mam-
mals, the other members of the Bacillus species are,
in general, only weakly virulent. B. cereus is ubiqui-
tous in the environment, being commonly found in
soil, air and water [1,2]. Recently, however, B. cereus
has been recognized to cause two di¡erent types of
food poisoning: the emetic type and the diarrheal
type, resembling that caused by Staphylococcus aur-
eus [3^5]. Non-anthrax species within clinical materi-
al, which were previously considered contaminants,
have increasingly been identi¢ed as pathogens. It has
become apparent that B. cereus may cause more seri-
ous and sometimes lethal infections such as sepsis,
pneumonia, meningitis, endocarditis, wound infec-
tion and ocular infection, especially in individuals
in an immunocompromised state, including those
with an acute leukemia, or acquired immunode¢-
ciency syndrome [6^9].
B. cereus produces a variety of extracellular en-
zymes and toxins, including a necrotizing enterotox-
in, an emetic toxin, phospholipases, proteases, and
hemolysins. With the exception of extracellular pro-
teases of B. cereus, it is well established that they all
are important pathogenic determinants [3^5,10^12].
Because extracellular and cell envelope-bound pro-
teases from other pathogenic microorganisms play
an important role in pathogenesis by activation of
the blood coagulation system [13], cleavage of serum
protease inhibitors [14,15], inactivation of comple-
ment factors [16] or in the invasiveness into the
host tissue [17], we investigated the occurrence of
membrane proteases in this species.
In this context, it is an important fact that cells
from B. cereus growing in the logarithmic phase on
peptide-rich medium display thus far unknown pro-
teins with high proteolytic activities in their cell en-
velopes. This membrane proteinase, called casein-
cleaving membrane proteinase (CCMP or camelysin)
was solubilized, puri¢ed and characterized to be a
neutral zinc metalloproteinase [18,19], which was un-
able to cleave the typical p-nitroanilide [20,21] and
furylacroleyl substrates [22] of the well-known extra-
cellular Bacillus proteases from subtilisin (EC
3.4.21.62) and thermolysin type (EC 3.4.24.27). Cam-
elysin could be solubilized from the cell exterior with
high concentrations of the zwitterionic detergent sul-
fobetain SB-12 and was enriched in the detergent
phase as a result of phase partition experiments
with non-ionic detergents [23]. This is evidence of
its amphipathic properties. The membrane proteinase
was fully accessible for its speci¢c polyclonal anti-
bodies and for protein substrates in intact cells [24]
^ a further indication for its localization at the exte-
rior of the cell envelope.
The determination of its cleavage, substrate and
inhibitor speci¢city and its in£uence on host defense
and matrix proteins is the subject of the following
article.
2. Materials and methods
2.1. Materials
The detergent sulfobetain SB-12 and the Clostridi-
um collagenase were purchased from Serva (Heidel-
berg, Germany). Acetonitrile (gradient grade), Frac-
togel EMD TMAE 650 (S), Fractogel TSK Butyl 650
(M), and calibration proteins VIII for the SDS^
PAGE (ovalbumin 42.7 kDa, glutamate dehydroge-
nase 56 kDa, ovotransferrin 78 kDa, phosphorylase
B 97.4 kDa, L-galactosidase 116.3 kDa) were ob-
tained from Merck (Darmstadt, Germany). Oxidized
bovine insulin A- and B-chains (disulfonate), plas-
minogen (Glu-type), streptokinase, K-casein, L-casein
and U-casein were purchased from Sigma (Deisenho-
fen, Germany). 14C-Methyl collagen, acid-soluble
was delivered by NEN (Boston, MA, USA). 125I-In-
sulin was iodinated by the chloramine T method as
described in detail recently [25].
The calpain substrates Boc-Leu-Met-AMC, Boc-
Met-Met-AMC and Boc-Leu-Leu-Met-AMC were
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synthesized by Dr. I. Willhardt. The other £uorogen-
ic protease substrates, aminopeptidase M, the anti-
bodies against human ¢brinogen and antithrombin
III as well as the anti-rabbit IgG^POD conjugate
were manufactured by Calbiochem (Bad Soden, Ger-
many) or Sigma.
The protease inhibitors DEPC, pCMB, o-phenan-
throline, zincov, phosphoramidon, thiorphan, Pefa-
bloc SC, elastatinal, leupeptin, antipain, and chymo-
statin were manufactured by Boehringer (Mannheim,
Germany) or Sigma.
2.2. Cultivation and puri¢cation
B. cereus cells were cultivated in a yeast extract
medium in a laboratory fermenter until mid-logarith-
mic growth phase, washed three times and adjusted
to a dry weight of 100 mg/ml in Tris^HCl bu¡er
(50 mM, pH 7.5, bu¡er A), based on a calibration
curve between optical density at 600 nm and dry
weight. Cells were treated with the same volume of
8% w/v sulfobetain SB-12 for 1 h while shaking
(150 rpm) at 20‡C. The supernatant (direct solubili-
zate) was separated from the sediment (intact cells
as microscopically proved) by centrifugation
(100 000Ug, 1 h) and stored at 320‡C.
Direct solubilizate was dialyzed overnight to reach
a detergent concentration of 0.2% w/v sulfobetain
SB-12 and adjusted to a saturation of 30% ammo-
nium sulfate. A Butyl-Toyopearl column (d = 2 cm,
l = 20 cm) was equilibrated with bu¡er I (bu¡er A
with 0.2% w/v sulfobetain SB-12 and 30% ammo-
nium sulfate saturation). After a prewash step with
150 ml of bu¡er I, the column was eluted at a £ow
rate of 0.5 ml/min with a 150 ml gradient of decreas-
ing ammonium sulfate concentration (from 100%
bu¡er I to 100% bu¡er II, bu¡er II = bu¡er A with
0.2% w/v sulfobetain SB-12) and an additional wash
step with 200 ml of bu¡er II. Fractions of 5 ml were
collected.
2.3. Determination of cleavage speci¢city
Camelysin was incubated with insulin A- and
B-chains (1:400 by mass) in ammonium carbonate
bu¡er, adjusted to pH 7.5, for various times (15,
30, 45, 60, 90 min) at 37‡C. The hydrolysis products
were identi¢ed by their molecular mass after separa-
tion on a 250U4 mm LiChroSpher 300 RP 18 (5 Wm)
column from Merck, using a Merck-Hitachi-LiChro-
Graph system with a L-6200 low-gradient pump, a
655-A UV detector and an HM-computing integra-
tor. Two di¡erent acetonitrile gradients were used for
the more hydrophobic insulin B-chain and the
shorter hydrophilic insulin A-chain, respectively. In
the case of the cleavage experiments with insulin
B-chain, the gradient started with 2% and ¢nished
with 70% acetonitrile after 70 min. For the insulin
A-chain, a gradient from 2% to 60% acetonitrile in
60 min was used. The £ow of the mobile phase was
set to 1 ml/min and the peptide absorption was
monitored at 220 nm.
For the fractionation of cleavage products, the an-
alytical HPLC was expanded to a semipreparative
250U10 mm Hi-Pore RP 318 column (Bio-Rad, Mu-
nich, Germany). In order to obtain identic retention
times of peptide fractions, the £ow of mobile phase
was adapted to 5 ml/min.
2.4. Mass spectrometry
MALDI mass spectrometry was performed on a
re£ectron-type time-of-£ight (TOF) mass spectrome-
ter (REFLEX, Bruker-Franzen Analytik, Bremen,
Germany). Ions formed by laser desorption at
337 nm (N2 laser) were recorded at an acceleration
voltage of 28.5 kV in the linear mode. The resulting
data were analyzed using the post-acquisition soft-
ware XMASS supplied with the spectrometer.
2.5. Cleavage of proteins and synthetic substrates
The proteolytic activity of the CCMP was deter-
mined with azocasein as the substrate by the method
of Langner et al. [26] and calculated as proteolytic
units (PU, 1 PU = 1 nmol azocasein cleaved per sec-
ond at 37‡C).
The cleavage of other proteins was determined
after 14C-acetylation of the substrate proteins [27]
as TCA-soluble peptides released in the supernatant
and subsequent scintillation counting. Additionally,
the cleavage of substrate proteins was assessed in
SDS^PAGE. 3H-Elastin labeled by the borohydride
method [28] was a gift from Prof. Dr. Kirschke (this
institute).
Assays with FALGPA (0.1 mM substrate concen-
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tration) were carried out by continuously monitoring
the decrease in absorbance of the substrate after the
addition of enzyme at 324 nm [29]. The enzymatic
activity was determined as the ratio of absorbance
change caused by the enzyme in relation to the value
for full hydrolysis (caused by 1 unit Clostridium col-
lagenase/assay) multiplied by the substrate concen-
tration.
The cleavage of AMC substrates was determined
in a continuous £uorometric assay (Vex 365 nm, Vem
440 nm, substrate concentration 20 WM, £uorescence
spectrophotometer F-2000, Hitachi). N-Protected
substrates with more than one amino acid were addi-
tionally tested in a coupled assay with an excess of
aminopeptidase M [30]. The internal cleavage sites of
camelysin for the substrates Suc-Leu-Leu-Val-Tyr-
AMC and Boc-Arg-Val-Arg-Arg-AMC were deter-
mined by online LC-MS analysis of the digested sub-
strates, using reversed phase HPLC coupled with an
ESQUIRE-LC ion trap mass spectrometer (Bruker
Daltonik, Germany).
Cleavage of the internally quenched Mca sub-
strates was measured at Vex 328 nm, Vem 393 nm
[31]. For the determination of the velocities, the £u-
orimeter was calibrated with 7-amino-4-methylcou-
marin or Mca-Pro-Leu, respectively, at the reported
wavelengths over a concentration range of 0.1^1 WM.
Cleavage products of Mca substrates were separated
by isocratic reversed phase HPLC (RP18 column,
ratio water to acetonitrile 75:25) and identi¢ed by
their £uorescence (Vex 328 nm, Vem 393 nm, spectro-
£uorometric detector RF-551, Shimadzu, Tokyo,
Japan).
The values of Km and Vmax were calculated using
the Enzpack 3 program (Biosoft, Ferguson, MO).
Because the hydrolysis of the present substrates fol-
lowed the normal Michaelis^Menten kinetics, the
plots of Lineweaver^Burk, Hanes^Wolf, and Eadie^
Hofstee resulted in essentially similar numerical val-
ues.
Protein content was determined by the bicincho-
ninic acid (BCA) method according to the manufac-
turer’s instructions (Bio-Rad).
2.6. Electrophoresis
The cleavage of substrate proteins was determined
by SDS^polyacrylamide gel electrophoresis in a dis-
continuous Tris/glycine system using gels of various
acrylamide concentrations (Mini-Protean II cell, Bio-
Rad, 1 mm thickness) [32]. Gels were stained with
Coomassie brilliant blue R-250. For the detection of
the plasminogen and antithrombin III complexes
with camelysin, the SDS gels were blotted on
PVDF membranes [33] and stained with colloidal
gold (Bio-Rad) according to the manufacturer’s in-
structions. Identical blots were treated with a poly-
clonal antibody (rabbit, 1/10 000 diluted) against the
substrate protein and developed with an anti-rabbit
IgG^POD conjugate (1/500 diluted).
For the staining of the puri¢ed camelysin, which is
di⁄cult to detect by Coomassie and silver staining,
samples were delipidated with a mixture (4:3:2 v/v)
of methanol, chloroform and distilled water [34] to
remove detergent and residual lipids. Following this,
gels were blotted onto PVD sheets and stained with
colloidal gold. The gels or blots were scanned and
evaluated with the software Phoretix 1D quanti¢er,
version 4 (Phoretix International, Newcastle upon
Tyne, UK).
2.7. Determination of the N-terminal sequence
The puri¢ed proteinase was desalted by reversed
phase HPLC on a C3 column (125U2 mm, 5 C3
500 PPN, Macherey-Nagel) at a £ow rate of 0.2
ml/min and with a gradient of 30^60% eluent B (elu-
ent A 0.09% TFA in water, eluent B 0.09% TFA in
acetonitrile). Additionally, 0.5 ml of the puri¢ed pro-
tein (30 Wg) were adsorbed on a ProSorb cartridge
(Perkin-Elmer Applied Biosystems, Weiterstadt, Ger-
many), washed two times with 0.5 ml 0.1% v/v TFA
solution and sequenced according to the manufactur-
er’s protocol (Protein Sequencer 476A, Perkin-Elmer
Applied Biosystems).
3. Results
3.1. Puri¢cation
The one-step puri¢cation with an isopropanol gra-
dient on TMAE-Fractogel, previously described, re-
sulted in a progressive inactivation of the puri¢ed
enzyme during dialysis and storage as a consequence
of denaturation by isopropanol [18]. We presumed
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that the strong self-aggregation of the puri¢ed pro-
teinase could also be an e¡ect of the organic solvent.
Therefore, we avoided the application of organic sol-
vents in the puri¢cation method described here and
developed another puri¢cation procedure using the
high hydrophobicity of camelysin and its localization
at the outer side of the cell envelope. The solubiliza-
tion of the membrane protease without the disinte-
gration of the cells resulted in a signi¢cant increase
of the speci¢c activity. Butyl-Toyopearl bound the
detergent-dissolved protease completely in the pres-
ence of 30% ammonium sulfate saturation in the de-
tergent bu¡er (Tris^HCl bu¡er 50 mM, pH 7.5 with
0.2% w/v sulfobetain SB-12) and thus in addition
allowed the elution of a partial activity by decreasing
the ammonium sulfate saturation (Fig. 1a). The azo-
caseinolytic activity was eluted at approx. 15^10%
ammonium sulfate saturation in the same fractions
as the proteolytic activity against the internally
quenched Mca substrate of the matrix metallopro-
tease (MMP) 2 and against Suc-Leu-Leu-Val-Tyr-
AMC. This suggested that the azocaseinolytic activ-
ity, described before [18], and the peptidolytic activ-
ity are properties of the same enzyme. Later inhibi-
tion experiments and an equal pH dependence also
Fig. 1. Puri¢cation of camelysin. (a) Puri¢cation of camelysin
on a Butyl-Toyopearl column (d = 2 cm, l = 20 cm). Direct solu-
bilizate was dialyzed against 0.2% w/v sulfobetain SB-12, ad-
justed to an ammonium sulfate saturation of 30% and eluted
with a gradient from 30% to 0% ammonium sulfate saturation.
999, OD at 280 nm; S, cleavage of Mca-Pro-Leu-Ala-Nva-
Dpa-Ala-Arg-NH2 (Wmol/minUfraction); b, cleavage of azoca-
sein (PU/fraction); 6C, pooled fractions. (b) Determination
of the molecular mass of the puri¢ed membrane proteinase
from B. cereus by MALDI-TOF mass spectrometry. TCA-pre-
cipitated protein was redissolved in 70% v/v formic acid. The
molecular mass of the membrane protease was determined to
be 19073.1 þ 15 Da. (c) Camelysin after puri¢cation on Butyl-
Toyopearl compared to calibration proteins and solubilizate
(10% polyacrylamide gels). After blotting onto PVDF sheets,
the blots were stained with colloidal gold. Lanes: 1, calibration
proteins (5 Wg); 2, direct solubilizate (15 Wg); 3, puri¢ed camel-
ysin (4 Wg); 4, calibration proteins. Arrows show the position
of the camelysin double band (58 kDa and 64 kDa). Samples
were delipidated, adjusted to 1 mM EDTA, 1% SDS w/v, and
5% w/v mercaptoethanol and boiled for 5 min. Calibration pro-
teins were as follows: ovalbumin (42.7 kDa), glutamate dehy-
drogenase (56 kDa), ovotransferrin (78 kDa), phosphorylase b
(97.4 kDa), L-galactosidase (116.3 kDa), myosin (200 kDa).
6
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support this assumption (Table 4). The optimal pH
for camelysin was between 6.5 and 7.5 for both the
azocaseinolytic activity and the cleavage of the
MMP2 substrate.
Only the ¢rst fractions of the proteolytic peak
were selected, because of the delayed desorption
from the matrix ^ a typical sign of strong hydropho-
bic interactions with the matrix and other bound
membrane proteins. The yield was acceptable with
regard to the purity of the eluted enzyme (Fig.
1b,c, Table 1). The stability of the puri¢ed enzyme
was signi¢cantly improved and su⁄cient for later
investigations of the substrate speci¢city. The yield
and puri¢cation factor of the azocaseinolytic activity
were lower than for the hydrolysis of the MMP2
substrate. We assume that the solubilizate contains
several proteinases, which cleave azocasein at multi-
ple sites. Only one of these proteolytic activities was
Table 1
Puri¢cation of camelysin on Butyl-Toyopearl
Puri¢cation step Protein (mg/fraction) Proteolytic activity Yield (%) Puri¢cation
factor
(a) PU/frct. (b) Wm/minUfrct. (a) (b) (a) (b)
Homogenized bacteria 148 8 120 62 060 100 100 1 1
Direct solubilizate 15 7 832 56 512 96.4 91.1 9.5 9.0
Dialysate 13.7 4 620 38 600 56.9 62.2 6.1 6.7
Pool after puri¢cation on
Butyl-Toyopearl
0.17 553 6 400 6.8 10.3 59.3 89.8
Pool after concentration and
dialysis
0.11 620 7 880 7.6 12.6 102.7 170.8
Values are averages of three di¡erent puri¢cation procedures.
(a) Azocasein as the substrate.
(b) MMP2 substrate (Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2).
Fig. 2. Cleavage speci¢city of camelysin for the insulin A- and B-chains in comparison to subtilisin, thermolysin and chymotrypsin C.
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puri¢ed and enriched. Therefore the hydrolysis of
azocasein was restricted to certain bonds in the pro-
tein molecule and was less e¡ective than before.
Without heating with SDS, the protein was highly
aggregated and was incapable to invade in the gel.
Upon boiling with SDS two blurred protein bands
(58 and 64 kDa) were visible (Fig. 1c) at the same
positions seen earlier in the result of the puri¢cation
on TMAE-Fractogel [18].
The same protein fraction as used for SDS electro-
phoresis was precipitated with TCA and dissolved
with 70% formic acid in preparation for mass spec-
trometry and sequencing. Only a single, uniform
peak was detected during desalting by reversed phase
Table 2
Hydrolysis of peptide derivatives of AMC, Mca or Fa type (3 Wg puri¢ed enzyme/assay)
Substrate Recommended use Relative rate of hydrolysis (%)
Without
aminopeptidase M
With
aminopeptidase M
Boc-Arg-Val-Arg-Arg-AMC Furin, Kex2 endoprotease ^ 46.18
Boc-Glu-Ala-Arg-AMC Factor XIa, plasmin 0.63 2.36
Boc-Glu-Lys-Lys-AMC Plasmin ^ 0.48
Boc-Gly-Lys-Arg-AMC Kex2 endoprotease 3.87 4.26
Boc-Leu-Met-AMC Calpain ^ ^
Boc-Leu-Leu-Met-AMC Calpain ^ ^
Boc-Met-Met-AMC Calpain ^ 0.58
Boc-Val-Gly-Arg-AMC Factor Xa, plasminogen activator 9.03 17.41
Boc-Val-Leu-Lys-AMC Plasmin 1.47 5.12
Bz-Phe-Val-Arg-AMC Thrombin ^ 0.52
FAGLA (0.1 mM) Thermolysin ^ n.d.
FALGPA (0.1 mM) Collagenases (+) n.d.
Mca-Pro-Leu-Gly-Pro-D-Lys(Dnp)-OH Thimet-oligopeptidase 12.2 n.d.
Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 Matrix metalloprotease 2/7 47.2 n.d.
Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 Matrix metalloprotease 2 100 n.d.
Mca-Pro-Leu-Ala-Gln-Ala-Val-Dap(Dnp)-Arg-Ser-
Ser-Ser-Arg-NH2
TNF-converting enzyme matrix
metalloprotease
95.6 n.d.
Suc-Ala-Ala-Phe-AMC Subtilisin, thermolysin ^ 3.89
Suc-Leu-Tyr-AMC Calpain, E. coli protease Ti ^ 6.07
Suc-Leu-Leu-Val-Tyr-AMC Chymotrypsin, papain, calpain 0.08 26.26
Z-Phe-Arg-AMC Kallikrein 2.97 5.28
Z-Arg-Arg-AMC Cathepsin B 1.65 14.63
(+), low hydrolysis at the detection limit, clearly detectable at ¢rst by the modi¢ed FALGPA assay of Jackson et al. [48].
n.d., not determined.
The reactions were carried out at 20‡C in Tris^HCl bu¡er (50 mM, pH 7.5) using 20 WM initial substrate concentration, if not de-
scribed otherwise. All AMC substrates with more than two amino acid residues were tested without and with aminopeptidase M. The
relative hydrolysis rate was determined setting the actual hydrolysis rate in relation to the highest hydrolysis rate. The relation be-
tween the concentration and £uorescence of AMC and Mca was determined by equilibration curves in the same £uorescence spectro-
photometer and £uorescence was corrected according to the £uorescence group used.
Table 3
Kinetic constants of the hydrolysis of substrates of camelysin from B. cereus
Substrate Km (WM) kcat (s31) kcat/Km (WM31 s31)
Suc-Leu-(s)-Leu-s-Val-Tyr-AMC+aminopeptidase M 91.8 50.7 0.55
Boc-Arg-s-Val-Arg-(s)-Arg-AMC+aminopeptidase M 20.0 29.82 1.49
Mca-Pro-Leu-s-Gly-Leu-Dpa-Ala-Arg-NH2 8.09 6.18 0.76
Mca-Pro-Leu-s-Ala-Gln-Ala-Val-Dap(Dnp)-Arg-Ser-Ser-Ser-Arg-NH2 9.32 18.90 2.03
Mca-Pro-Leu-s-Ala-Nva-Dpa-Ala-Arg-NH2 7.70 23.40 3.04
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HPLC (data not shown) and in the MALDI-TOF
mass spectrometry (19.073 þ 0.015 kDa) (Fig. 1b).
This discrepancy between the results obtained from
SDS electrophoresis and mass spectrometry implies
the formation of SDS-resistant aggregates, even after
boiling with SDS. The N-terminus of the HPLC-de-
salted protein was identical with the directly blotted
protein sample without traces of other sequences
and was determined as follows: Phe-Phe-Ser-Asp-
Lys-Glu-Val-Ser-Asn-Asn-Thr-Phe-Ala-Ala-Gly-Thr-
Leu-Asp-Leu-Thr-Leu-Asn-Pro-Lys-Thr-Leu-Val-
Asp-(Ile-Lys-Asp)-.
The N-terminal sequence was reported to the PIR
protein data base with the accession No. S78771. No
high-homologous sequences were found in the result
of the investigations in protein sequence data banks
using the BLAST P algorithm. Thus, camelysin is a
novel protein without protein sequence homologies
to the known extra- and intracellular proteinases
from Bacillus strains.
3.2. Cleavage speci¢city
Both insulin chains were cleaved by camelysin.
Arising cleavage peptides were separated by reversed
phase HPLC with an acetonitrile gradient and deter-
mined by mass spectrometry. When peptides could
not be clearly identi¢ed on the basis of their molec-
ular weights, N-terminal sequencing was performed.
Some cleavage sites of the insulin B-chain were lo-
cated nearby (11^12, 13^14, 16^17, 17^18), therefore
single amino acids and short peptides were formed
and eluted right after the bu¡er peak in the gradient.
Nevertheless, the assignment of cleavage sites was
unequivocal and could be con¢rmed by mass spec-
trometric investigation of the total cleavage peptides
without HPLC separation.
The following cleavage sites of insulin B-chain
were obtained: Leu11-s-Val12, Glu13-s-Ala14,
Tyr16-s-Leu17, Leu17-s-Val18, Tyr26-s-Thr27. The
cleavage sites of the insulin A-chain were determined
alike: Ala8-s-Ser9,Tyr14-s-Gln15, Gln15-s-Leu16,
Tyr19-s-Cys20.
It was not possible to discriminate between pri-
mary and secondary cleavage sites. All larger cleav-
age peptides could be detected after 30 min. Princi-
pally, camelysin cleaved peptide bonds between two
aliphatic amino acid residues or two amino acid res-
idues with a hydrophilic side chain (^OH, ^SO3H,
^COO3, amido group) as well as peptide bonds con-
taining a combination of both types. No cleavage
occurred in front of Phe or Tyr. Camelysin had
some similar cleavage sites as subtilisin, thermolysin
and chymotrypsin C (EC 3.4.21.2), but it was inca-
pable of hydrolyzing the signi¢cant bonds cleaved by
these proteases between aromatic amino acids as
Phe24-Phe25 and Phe25-Tyr26 in the insulin B-chain
(Fig. 2) [35,36], where an aromatic amino acid is
placed in the P1P position.
Since a previous search for the hydrolysis of N-
protected p-nitroanilide substrates revealed no hy-
drolytic activity, we tested the destruction of the
more sensitive £uorogenic AMC substrates in a
coupled assay with aminopeptidase M to detect in-
Fig. 3. Separation of the cleavage products of the substrate
Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by HPLC. During the
measurement of a continuous assay (20 WM substrate, 3 Wg pu-
ri¢ed camelysin in Tris^HCl bu¡er), samples of 100 Wl were
taken every 15 min, protein was precipitated by acidi¢cation
with 1% v/v TFA and centrifugation. The clear supernatants
were separated on a RP18 column (20 Wl, ANF:water 25:75,
0.1% TFA, £ow 1 ml/min, £uorescence detector Vex 328 nm,
Vem 393 nm). The system was calibrated with a mixture (1:1) of
Mca-Pro-Leu and Mca-Pro-Leu-Gly (5 Wl of a 0.1 WM solution,
dissolved in DMSO, were injected).
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ternal cleavage sites. Corresponding to the cleavage
speci¢city for insulin chains, camelysin avoided hy-
drophobic aromatic residues in the P1P position (Ta-
bles 2 and 3). Therefore, chromogenic substrates of
p-nitroanilide and AMC-type are poor substrates.
Only oligopeptide AMC substrates with Arg in the
P1 position, for example Boc-Val-Gly-Arg-AMC,
were accepted, although still with a low hydrolysis
rate.
Quenched £uorogenic substrates of MMPs were
highly speci¢c substrates with low Km values (Table
3). The typical cleavage site of MMPs is the bond
Gly-s-Leu in the MMP2/7 substrate [31]. That
means that these proteases prefer the smaller ali-
phatic residue of the scissile bond in the S1 pocket
[37]. Camelysin hydrolyzed the same substrates, but
with preference for the smaller residue in the S1P
subsite. Only the £uorogenic peptide Mca-Pro-Leu
was formed proportional to the time. The other pos-
sible cleavage product MCA-Pro-Leu-Gly could not
be detected (Fig. 3). The cleavage of the MMP2
substrate and the TACE substrate occurred at the
same bond, also forming Mca-Pro-Leu (data not
shown).
The hydrolysis of the collagenase substrate FALG-
PA by the puri¢ed enzyme was near the detection
limit, too low for the determination of kinetic param-
eters. FALGPA is an insensitive substrate in compar-
ison to the Mca substrates used. Full hydrolysis of
100 nM FALGPA/assay resulted only in an absor-
bance decrease of 0.27 at 324 nm, whereas the release
of 0.1 nM Mca-Pro-Leu caused a £uorescence in-
crease of approx. 300 £uorescence units. Therefore,
the low cleavage of FALGPA should not be directly
compared to the £uorogenic AMC substrates (Table
2) and was marked only with the sign (+).
3.3. Inhibition pattern of camelysin
The sensitivity of camelysin against various inhib-
itors demonstrated that the puri¢ed protease belongs
to the metalloproteases (Table 4). Only chelators like
EDTA and o-phenanthroline caused a strong inhibi-
tion. Inhibitors of serine and cysteine proteases were
Table 4
In£uence of protease inhibitors on the activity of puri¢ed camelysin
Inhibitor Use recommended Residual activity (%)
Azocasein MMP2 substrate
EDTA (1 mM) Metalloprotease 0 0.9
o-Phenanthroline (1 mM) Metalloprotease 0 0
PMSF (1 mM) Serine protease 76 74
Pefabloc (1 mM) Serine protease 90 73.6
pCMB (1 mM) Cysteine protease 75 63.5
Iodoacetamide (1 mM) Cysteine protease 76 65.5
DEPC (10 mM) Modi¢cation of histidyl residues 5 10.4
N-CBZ-Phe-CK (1 mM) Chymotrypsin-like proteases 69.2 60.9
N-CBZ-Ala-Leu (1 mM) Thermolysin 97.5 71.8
N-CBZ-D-Phe (1 mM) Thermolysin 77 52.5
Captopril (200 WM) ACE 86.5 77.8
Chymostatin (200 WM) Chymotrypsin-like proteases 74.3 64.3
E-64 Cysteine proteases 91 86
Elastatinal (10 WM) Elastases 104 96
MMP1 inhibitor (100 WM) MMP 86.4 73.6
Phosphoramidon (200 WM) Thermolysin Ki = 28 nM [39] 96.5 80.9
Thiorphan (100 WM) Neprilysin Ki 3.5 nM [39] 98 89.8
Zincov (100 WM) Thermolysin Ki = 480 nM [40] 98 94.9
Zn2 (100 WM) Zinc metalloproteases 89 83.9
Zn2 (1 mM) Zinc metalloproteases 28 34
Enzyme (3 Wg/assay) and inhibitors were preincubated for 15 min at room temperature, then the residual activity was determined as
described in Section 2 (azocasein assay or continuous assay with 20 WM Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2, Tris^HCl bu¡er
50 mM, pH 7.5). Results are averages of determinations in triplicate.
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without signi¢cant in£uence. The lacking e⁄ciency
of speci¢c inhibitors for thermolysin-like proteases
(family M4) (phosphoramidon, zincov) [38^40] con-
¢rmed that camelysin is not a member of this pro-
tease family. Therefore, we can exclude that camel-
ysin is a membrane-bound, intermediate processing
product of the extracellular neutral protease. The
speci¢c peptide inhibitor of matrix metalloproteases
4-Abz-Gly-Pro-D-Leu-D-Ala-NHOH showed only a
low inhibition e¡ect, consistent with a di¡erence in
the way camelysin interacts with substrates (Fig. 3).
3.4. Cleavage of proteins
Among the signi¢cant host proteins tested, G-ac-
tin, K2-antiplasmin, K1-antitrypsin, collagen type I,
¢brinogen and ¢brin were degraded (Figs. 4, Tables
5 and 6). Puri¢ed camelysin was not visible in Coo-
massie staining as is shown in Fig. 4a,b (lane 2).
Fibrinogen chains of K- and L-type were completely
cleaved after 2 h of incubation unlike the Q-chains,
Table 5
Cleavage of radioactively labeled proteins by camelysin from B.
cereus
Substrate protein Relative cleavage (%)
14C-Casein, acetylated 100
14C-Collagen, methylated, acid soluble 58
14C-Ovalbumin, acetylated 2.8
14C-Globin, acetylated 1.7
14C-Bacteriorhodopsin, acetylated 0.006
3H-Elastin 7.0
125I-Insulin 1.4
Substrate proteins were used in a concentration of 5 Wg/assay
and incubated with 3 Wg puri¢ed camelysin for 1 h at 37‡C.
Results are averages of quadruple determinations.
Fig. 5. Cleavage of signi¢cant host proteins. (a) G-Actin (10%
acrylamide); (b) collagen type I (10% acrylamide); (c) K2-anti-
plasmin (10% acrylamide); (d) K1-antitrypsin (12.5% acrylam-
ide). Lanes: 1, substrate blank; 2, main value, 2 h incubation.
Fig. 4. Cleavage of ¢brinogen and ¢brin by camelysin (enzy-
me:substrate ratio 1:20, w/w). (a) Fibrinogen cleavage, 7.5% ac-
rylamide, reducing conditions, Coomassie staining. Lanes: 1,
calibration proteins (ovalbumin 42.7 kDa, glutamate dehydroge-
nase 56 kDa, ovotransferrin 78 kDa, phosphorylase b 97.4
kDa, L-galactosidase 116.3 kDa, myosin 200 kDa); 2, enzyme
blank; 3, substrate blank; 4, main value, 2 h incubation;
5, main value, 4 h incubation. (b) Fibrin cleavage, 10% acryl-
amide, reducing conditions, Coomassie staining. Lanes: 1, cali-
bration proteins (see above); 2, enzyme blank; 3, substrate
blank; 4, main value, 2 h incubation; 5, main value, 4 h incu-
bation. The enzyme and the substrate blanks were incubated
for 4 h. (c) Fibrin cleavage by plasmin, 10% acrylamide, reduc-
ing conditions, Coomassie staining. Lanes: 1, calibration pro-
teins (see above); 2, main value with plasmin. Plasmin (0.2 U)
was incubated with ¢brin for 4 h at 37‡C.
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which remained visible in the gel. Fibrinolysis was
tested with freshly prepared and washed ¢brin clots
following the method from Thomas et al. [41]. The
blank of washed ¢brin clots (4 h incubation) showed
no hydrolysis peptides. Camelysin released large
cleavage products from the ¢brin clots, some with
a similar molecular mass to the ¢brinogen single
chains, when we compare the cleavage pattern with
Fig. 4a.
In Fig. 5, only the substrate blanks and main val-
ues after 2 h of incubation are displayed. Type I
collagen is a heterotrimer that consists of two iden-
tical K1-chains and a non-identical K2-chain. This
type is by far the most abundant collagen and com-
prises a large percentage of skin, bone and tendon.
Bacterial collagenases are characterized by their abil-
ity to make multiple incisions within the triple helical
region of collagen [42]. Camelysin cleaved collagen
type I in a similar manner as described for bacterial
collagenases. Only small cleavage peptides were
formed, which were not detectable in the gel.
Besides K2-macroglobulin, K2-antiplasmin and K1-
antitrypsin are the most important serum proteinase
inhibitors, regulating the activity of plasmin and of
blood elastase, respectively. The glycoprotein K2-
antiplasmin associates with the K-chains of ¢brin
and inactivates plasmin by forming irreversible equi-
molar complexes. The complete destruction of K2-
antiplasmin by the membrane proteinase from
B. cereus (Fig. 5c) favors ¢brinolysis.
Antithrombin III and plasminogen formed com-
plexes with puri¢ed camelysin, recognizable by addi-
tional di¡use bands in the upper regions of the lanes
for the main values, which were not visible before in
Fig. 6. Formation of protease^substrate protein complexes with
human antithrombin III (10% acrylamide, non-reducing condi-
tions, 4 h incubation). Lanes: 1, calibration proteins; 2, puri¢ed
enzyme; 3, substrate protein; 4, main value (enzyme:substrate
ratio 1:20, w/w); 5, main value (enzyme:substrate 1:10);
6, main value (enzyme:substrate 1:5). (a) Gold staining after
blotting. (b) Western blot with anti-antithrombin III (rabbit,
1:10 000) and anti-rabbit IgG^POD conjugate (goat, 1:500).
Camelysin^substrate complexes are marked with c1 and c2.
Table 6
Cleavage of proteins by camelysin from B. cereus
Protein Cleavage by camelysin
Actin, bovine muscle +
K1-Antitrypsin, human plasma +
K2-Antiplasmin, human plasma +
Antithrombin III, human plasma (+)c
K-Casein +
L-Casein +
U-Casein +
Collagen type I, bovine +
C-Reactive protein, human ascites 3
Fibrinogen, human plasma +
Fibrin, human plasma +
Fibronectin, human 3
Globin +
Human serum albumin +
IgA, human 3
IgG, human 3
Lactoferrin, human milk (+)
Laminin 3
Lysozyme, chicken egg 3
K2-Macroglobulin (+)
Plasminogen, human +c
Transferrin, human plasma 3
Enzyme to substrate protein ratio 1:20 by mass. Cleavage was
determined by SDS^polyacrylamide electrophoresis and com-
pared to substrate and enzyme blanks.
c, formation of complexes.
(+), partial cleavage after 4 h incubation.
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the enzyme or the substrate blanks (Figs. 6 and 7).
These higher molecular complexes consist of the
membrane protease and the substrate protein which
can be demonstrated by Western blotting with anti-
bodies against antithrombin III and plasminogen.
Antithrombin III is described to form 1:1 complexes
with all proteinases of the blood coagulation system.
One of the multiple complexes with camelysin (Fig.
6b, marked with c1) corresponds to the sum of the
apparent molecular mass for the camelysin band
doublet (enzyme blank, lane 2) and of antithrombin
III. Additionally, a partial cleavage of antithrombin
III became visible. A similar complex formation is
described between thrombin and antithrombin III.
This complex is so solid that it does not dissociate
in SDS electrophoresis [43].
Camelysin cleaved plasminogen at the typical
cleavage site for plasminogen activators Arg561-
Lys562 [44]. Under reducing conditions, the two
chains of plasmin formed dissociates in the SDS elec-
trophoresis. Bands with molecular masses corre-
sponding to the two chains of the mature plasmin
were identi¢ed: heavy chains in the Glu1 and the
Lys78 form (63.2 and 54.4 kDa) and the catalytically
active light chain (25.2 kDa) (Fig. 7a,b) [45]. These
molecular masses were calculated with the Protpar-
am software from the Expasy website for the non-
glycosylated form (plasminogen is glycosylated at
variable sites to various degrees). The removal of
the N-terminal 77-residue preactivation peptide is a
typical action of the formed plasmin [45]. The band
of Glu1 plasminogen lost approx. 65% of its intensity
(calculated with the Phoretix 1D software). Besides
these typical cleavage products, by-products were
formed, which could not clearly be characterized;
presumably, camelysin cleaves plasminogen at addi-
tional sites.
We investigated if complex formation between
camelysin and plasminogen changed the plasmin-
(ogen) activity. Because camelysin does not cleave
the plasmin substrate Boc-Glu-Lys-Lys-AMC (Table
2), the conversion of plasminogen to plasmin was
followed with this substrate in a continuous assay.
Fig. 8. Activation of plasminogen by camelysin and streptoki-
nase. Plasminogen, Glu-type, was incubated alone, with strepto-
kinase (molar ratio 1:1) or with camelysin (molar ratio 1:1) at
30‡C over time. Aliquots of 20 Wl were taken and diluted 1/50
in the following continuous assay with the plasmin substrate
Boc-Glu-Lys-Lys-AMC at 30‡C (20 WM substrate concentra-
tion, Tris^HCl bu¡er, pH 7.5, 50 mM). Results are averages of
quadruple determinations. b, plasminogen blank; F, plasmino-
gen and camelysin without ¢brin; 7, plasminogen and camely-
sin with ¢brin; P, plasminogen and streptokinase.
Fig. 7. Formation of protease^substrate protein complexes with
human plasminogen and plasminogen cleavage (10% acrylam-
ide, reducing conditions, 4 h incubation). Lanes: 1, calibration
proteins; 2, puri¢ed enzyme; 3, substrate protein; 4, main value
(enzyme:substrate ratio 1:20, w/w); 5, main value (enzyme:sub-
strate 1:10); 6, main value (enzyme:substrate 1:5). (a) Gold
staining after blotting. (b) Western blot with anti-plasminogen
(rabbit, 1:10 000) and anti-rabbit IgG^POD conjugate (goat,
1:500).
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Camelysin or streptokinase as model activator were
incubated with plasminogen at 30‡C over a time pe-
riod of 8 h. Samples were taken and diluted 50-fold
in the assay. Camelysin caused a fast, but only low
activation of plasminogen in the ¢rst hour (Fig. 8). A
¢nal activation of 31.4 þ 2.4% in the presence of ¢-
brin and of 9.8 þ 2.1 without ¢brin were obtained
compared to the optimal activation of plasminogen
by streptokinase. The formed plasmin is better pro-
tected against autolysis and proteolysis in the pres-
ence of ¢brin.
4. Discussion
This study reports the substrate and inhibitor
characteristics of a novel protease from B. cereus.
This enzyme is the ¢rst membrane bound metallo-
protease from a Bacillus species with a clearly di¡er-
ent substrate and inhibitor speci¢city in comparison
to the extracellular subtilisin- and thermolysin-like
proteases. In early investigations of Strongin et al.
[46] and Ma«ntsa«la et al. [47], the presence of mem-
brane-bound proteases in Bacillus species was pro-
ven, but these enzymes seemed to be only loosely
attached extracellular proteases, because they were
soluble by low concentrations of non-ionic detergents
and had the same properties as these proteases.
However, camelysin was tightly bound to the cell
envelope and was clearly di¡erent in its substrate
and inhibitor speci¢city (Tables 2 and 4); therefore,
we can exclude that we have puri¢ed and character-
ized a proform of extracellular proteases. Recently,
Jackson et al. [48] detected hydrolytic activity against
FALGPA associated to the cell envelope of B. cereus
by a more sensitive, modi¢ed assay (24 h incuba-
tion). This collagenolytic activity was only inhibited
by chelators and could be identical with camelysin.
Unfortunately, these authors performed no further
puri¢cation and characterization.
The main problem in handling this membrane pro-
tein was its lability and self-aggregation tendency
despite detergent concentrations above the CMC.
Each kind of puri¢cation on column matrices re-
sulted in a high loss of activity although the solubi-
lized form was stabile and active over a long time at
4‡C. With the puri¢cation procedure presented here,
a stable pure protease preparation could be obtained,
which allowed the further characterization of the en-
zyme.
The SDS-resistant aggregation of camelysin in the
SDS electrophoresis is not easy to explain. Usually,
ionic detergents like SDS eliminate ionic and hydro-
phobic associations between protein subunits [49,50].
SDS-resistant aggregations of proteins have been
described rarely ^ examples are the dimerization of
glycophorin-A [51] and of K-hemolysin from
S. aureus [52] as well as the oligomerization of the
monoamine transporter [53] despite boiling in SDS.
These authors have interpreted the phenomenon as
strong hydrophobic interactions between the mono-
mers, which cannot be dissolved by detergent. The
extent to which the oligomerization of camelysin in
the SDS electrophoresis was caused by changes in the
secondary or tertiary protein structure of the mono-
mers during puri¢cation and their resulting variable
phospholipid and detergent binding cannot be an-
swered at present and will be the subject of further
investigations.
Cleavage speci¢city of camelysin for the oxidized
insulin A- and B-chains is clearly di¡erent from that
of thermolysin and subtilisin, similar only in some
sites [35]. The exclusion of aromatic residues from
the S1P pocket was the most remarkable di¡erence
to these proteases, an unusual phenomenon among
cleavage speci¢cities described for proteases. We
were unable to ¢nd a similar cleavage pattern in
literature references.
The S1P speci¢city pocket must accommodate the
chromophoric or £uorescent aromatic leaving group
of the synthetic peptide substrates ^ that is the pre-
condition for the detectable cleavage of chromogenic
and £uorogenic peptide substrates. Some membrane
proteases like omptin (EC 3.4.21.27) [54] and nepri-
lysin (EC 3.4.24.11) [55] do not accept a larger aro-
matic residue in this position and must be deter-
mined by a coupled assay with a broad speci¢city
aminopeptidase or with an internally quenched £uo-
rogenic substrate derived from an accepted peptide
sequence. Camelysin was shown to cleave acid-solu-
ble 14C-collagen and collagen type I. That was the
reason for testing the sensitive, internally quenched,
£uorogenic substrates of matrix metalloproteases.
Such Mca substrates were the best accepted sub-
strates of our membrane protease from B. cereus
with high e⁄ciency parameters (Table 3). Bacterial
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collagenases like clostridial collagenase (EC 3.4.24.3)
[56] and fragilysin from Bacteroides fragilis (EC
3.4.24.74) [57] cleave collagen-derived peptide sub-
strates in the same manner as camelysin between
the Leu-s-Gly bond [57,58]. Clostridium collagenases
resemble camelysin in its behavior against phosphor-
amidon (no inhibition) and in the ine¡ectivity of in-
hibitors of matrix metalloproteases [42,58].
As far as we know, camelysin is the ¢rst described
membrane-bound collagenolytic protease of a Gram-
positive bacterium species showing all properties of a
possible pathogenicity factor. It cleaves collagen and
actin, degrades ¢brinogen and ¢brin, forms SDS-re-
sistant complexes with plasminogen and antithrom-
bin and causes a partial activation of plasminogen to
plasmin.
Some pathogenic Gram-negative microorganisms
(Yersinia pestis, Escherichia coli, Salmonella typhimu-
rium) bind host plasmin(ogen) on their surfaces, us-
ing the host protease after their activation for the
penetration of ¢brin clots and of the extracellular
matrix [17,59,60]. Camelysin is located on the exteri-
or of the bacterial cell, binds plasminogen, activates
it partially and destroys K2-antiplasmin, shifting
hereby the equilibrium of the blood coagulation sys-
tem to the ¢brinolysis site. We believe camelysin
could be a receptor for plasmin(ogen) and applies
host plasmin for its invasion into host tissue, addi-
tional to its own ¢brinolytic action.
Cleavage of actin was described as an important
interaction mechanism of the Vibrio cholerae hemag-
glutinin/protease with epithelial cells, thereby causing
morphological changes and perturbing the paracellu-
lar barrier [61]. The enterotoxin fragilysin causes
damage to the intestinal epithelium by degrading
the tight junctions and basement membranes, thus
bringing about £uid accumulation and intestinal
damage in vivo [62]. Similar to camelysin, fragilysin
cleaves collagen, ¢brinogen, actin and K1-proteinase
inhibitor [57,63]. In this context, we will investigate if
the well-known diarrheal e¡ects of B. cereus [4,5] are
also the result of camelysin interaction with intestinal
cells.
Beecher et al. [64] postulate that the B. cereus en-
dophthalmitis, a severe post-traumatic eye disease, is
the result of three pathogenicity factors ^ of the tri-
partite hemolysin BL, of the phosphatidylcholine-
preferring phospholipase C and of a hypothetical
collagenase, breaking down the protecting collagen
of the lens capsule [64]. Similarly, the participation
of an unidenti¢ed collagenase, bound at the surface
of B. cereus cells, was believed to participate in the
adhesion to host cells in the logarithmic phase [65].
Because camelysin is only stable in the presence of
detergent, the membrane protease must be reconsti-
tuted into liposomes, before it will be possible to test
its e¡ect on eukaryotic cells without the disturbing
e¡ects of detergents.
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